New combo therapy aims to save rectums from surgery
NCT ID NCT06417476
First seen Apr 16, 2026 · Last updated May 02, 2026 · Updated 2 times
Summary
This study tests two types of radiation (short or long course) followed by a strong chemotherapy combo (mFOLFOXIRI) in people with low rectal cancer. The goal is to shrink the tumor enough to avoid major surgery and keep the rectum working normally. About 66 adults with stage T2-4a rectal cancer will take part to see if this approach can safely preserve the organ.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
651 Dongfeng Road East
Guangzhou, Guangdong, 510060, China
Conditions
Explore the condition pages connected to this study.